Literature DB >> 962421

Comparative study of 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine and its enantiomorphs on analgesic and othe pharmacological activities in experimental animals.

H Nakamura, M Shimizu.   

Abstract

The analgesic activity of (+/-)-1-cycylohexyl-4-(1,2-diphenylethyl)-piperazine (MT-45) was comparable to that of morphine. The activity of the S(+)-isomer was 1.14 to 1.97 times in mice and 1.00 and 1.23 times in rats as potent as MT-45, and 18.3 to 61.6 times as potent as the R(--)isomer, which was approximately comparable to that of Spa. The hyperglycemic and miotic activities of MT-45 and its S(+)-isomer in rabbits were negligible or very low, though they showed potent morphine-like activites. On the other hand, the R(--)-isomer showed no or very weak effects on those, while Spa showed definite effects. These results suggest that the modes of action of MT-45 and its enantiomorphs are partly different from those of morphine and Spa, and it may be concluded that MT-45 belongs to a new series of compounds having a potent analgesic activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962421

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  7 in total

1.  Pharmacological characterizations of the 'legal high' fluorolintane and isomers.

Authors:  Jason Wallach; Tristan Colestock; Julià Agramunt; Matt D B Claydon; Michael Dybek; Nadine Filemban; Muhammad Chatha; Adam L Halberstadt; Simon D Brandt; David Lodge; Zuner A Bortolotto; Adeboye Adejare
Journal:  Eur J Pharmacol       Date:  2019-05-29       Impact factor: 4.432

2.  Super-active enkephalin analogues. Simple tripeptide hydroxyalkylamides exhibit surprisingly high and long-lasting opioid activities.

Authors:  Y Kiso; M Yamaguchi; T Akita; H Moritoki; M Takei; H Nakamura
Journal:  Naturwissenschaften       Date:  1981-04

3.  Dexamethasone fails to produce antipyretic and analgesic actions in experimental animals.

Authors:  H Nakamura; Y Mizushima; Y Seto; S Motoyoshi; T Kadokawa
Journal:  Agents Actions       Date:  1985-09

Review 4.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

5.  Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats.

Authors:  Ellen A Walker; Christina Chambers; Matthew G Korber; Srihari R Tella; Cassandra Prioleau; Li Fang
Journal:  J Pharmacol Exp Ther       Date:  2021-07-08       Impact factor: 4.402

6.  Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.

Authors:  Craig McKenzie; Oliver B Sutcliffe; Kevin D Read; Paul Scullion; Ola Epemolu; Daniel Fletcher; Anders Helander; Olof Beck; Alexia Rylski; Lysbeth H Antonides; Jennifer Riley; Shannah A Smith; Niamh Nic Daeid
Journal:  Forensic Toxicol       Date:  2018-04-05       Impact factor: 4.096

7.  Activation of μ-opioid receptors by MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) and its fluorinated derivatives.

Authors:  Daniel T Baptista-Hon; Mark Smith; Samuel Singleton; Lysbeth H Antonides; Niamh Nic Daeid; Craig McKenzie; Tim G Hales
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.